From: Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer
Response
No.(%)
Complete Response
4 (11)
Partial Response
7 (20)
Overall Response Rate (CR+PR)
11 (31)
Stable disease
15 (43)
Tumor control rate (CR+PR+SD)
26 (74)
Progressive disease
9 (26)